Literature DB >> 10335303

Development of a biodegradable antibiotic delivery system.

S S Lin1, S W Ueng, S J Liu, E C Chan, E K Chao, C H Tsai, K T Chen, F C Wei, C H Shih.   

Abstract

Antibiotic beads have been used as a drug delivery system for the treatment of various surgical infections. In this study, the copolymer 50:50 poly(DL-lactide):co-glycolide was mixed with vancomycin powder and hot compressing molded at 55 degrees C to form five types of biodegradable antibiotic beads. The beads were placed in 1 mL of phosphate buffered saline and incubated at 37 degrees C. The phosphate buffered saline was changed daily, and the removed buffer solutions were stored at -70 degrees C until the antibiotic concentration in each sample was determined by high performance liquid chromatography system assay. The concentration of vancomycin in each sample was well above the breakpoint sensitivity concentration (the antibiotic concentration at the transition point between bacterial killing and resistance to the antibiotic) for more than 32 days. The release was most marked during the first 48 hours. All copolymer 50:50 poly(DI lactide):co-glycolide biodegradable beads released high concentrations of the antibiotics in vitro for the time needed to treat bone infections (4 to 6 weeks). The diameter of the sample inhibition zone ranged from 6.5 mm to 10 mm, and the relative activity of vancomycin ranged from 12.5% to 100%. Copolymers with low heat of formation temperatures are required for making a controlled release system to prevent antibiotic decomposition, which occurs when using the hot compressing molded method. The rate and duration of release from the antibiotic beads can be adjusted by varying the diameter of the beads. This offers a convenient method to adjust the release rate to meet the specific antibiotic requirements for different patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10335303

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  5 in total

1.  In vitro and in vivo investigation of drug-eluting implants for the treatment of periodontal disease.

Authors:  Fu-Ying Lee; Dave W Chen; Chih-Chien Hu; Yu-Te Hsieh; Shih-Jung Liu; Err-Cheng Chan
Journal:  AAPS PharmSciTech       Date:  2011-08-31       Impact factor: 3.246

2.  Cefazolin-loaded mesoporous silicon microparticles show sustained bactericidal effect against Staphylococcus aureus.

Authors:  Iman K Yazdi; Matthew B Murphy; Christopher Loo; Xuewu Liu; Mauro Ferrari; Bradley K Weiner; Ennio Tasciotti
Journal:  J Tissue Eng       Date:  2014-05-19       Impact factor: 7.813

3.  A Fully Functional Drug-Eluting Joint Implant.

Authors:  V J Suhardi; D A Bichara; Sjj Kwok; A A Freiberg; H Rubash; H Malchau; S H Yun; O K Muratoglu; E Oral
Journal:  Nat Biomed Eng       Date:  2017-06-13       Impact factor: 25.671

4.  A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis.

Authors:  Daniëlle Neut; Otto S Kluin; Bart J Crielaard; Henny C van der Mei; Henk J Busscher; Dirk W Grijpma
Journal:  Acta Orthop       Date:  2009-10       Impact factor: 3.717

5.  Efficacy of vancomycin-releasing biodegradable poly(lactide-co-glycolide) antibiotics beads for treatment of experimental bone infection due to Staphylococcus aureus.

Authors:  Steve W N Ueng; Song-Shu Lin; I-Chun Wang; Chuen-Yung Yang; Ru-Chin Cheng; Shih-Jung Liu; Err-Cheng Chan; Cheng-Fen Lai; Li-Jen Yuan; Sheng-Chieh Chan
Journal:  J Orthop Surg Res       Date:  2016-04-27       Impact factor: 2.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.